Is histone deacetylase-9-MicroRNA-17∼92 cluster a novel axis for angiogenesis regulation?

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 3, 2013, Pages 445-446

  Sato, Yasufumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; HISTONE DEACETYLASE 9; HYDROLASE; MICRORNA; MICRORNA 17-92; ROMIDEPSIN; SPACER DNA; UNCLASSIFIED DRUG; VASCULOTROPIN A; VORINOSTAT;

ANGIOGENESIS; DEACETYLATION; EDITORIAL; EPIGENETICS; GENE CLUSTER; GENE EXPRESSION REGULATION; HEMATOLOGIC MALIGNANCY; HISTONE ACETYLATION; HISTONE MODIFICATION; ISCHEMIA; NUCLEAR LOCALIZATION SIGNAL; POSITIVE FEEDBACK; PRIORITY JOURNAL; SCIENTIFIC LITERATURE; ZEBRA FISH;

ANIMALS; HISTONE DEACETYLASES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; ISCHEMIA; MICRORNAS; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; REPRESSOR PROTEINS; RETINAL NEOVASCULARIZATION; ZEBRAFISH PROTEINS;

EID: 84874354448     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300989     Document Type: Editorial

References (10)

1. Breving K, Esquela-Kerscher A. The complexities of microRNA regulation: mirandering around the rules. Int J Biochem Cell Biol. 2010;42:1316-1329.
2. Nicoli S, Standley C, Walker P, Hurlstone A, Fogarty KE, Lawson ND. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature. 2010;464:1196-1200.
3. Small EM, Sutherland LB, Rajagopalan KN, Wang S, Olson EN. MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling. Circ Res. 2010;107:1336-1344.
4. Bonauer A, Carmona G, Iwasaki M, et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science. 2009;324:1710-1713.
5. Hassel D, Cheng P, White MP, Ivey KN, Kroll J, Augustin HG, Katus HA, Stainier DY, Srivastava D. MicroRNA-10 regulates the angiogenic behavior of zebrafish and human endothelial cells by promoting vascular endothelial growth factor signaling. Circ Res. 2012;111:1421-1433.
6. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 2009;460:705-710.
7. Wang Z, Yao H, Lin S, Zhu X, Shen Z, Lu G, Poon WS, Xie D, Lin MC, Kung HF. Transcriptional and epigenetic regulation of human microRNAs. Cancer Lett. December 11, 2012. doi: 10.1016/j.canlet.2012.12.006. http://www.cancerletters. info/article/S0304-3835(12)00723-9/abstract. Accessed January 31, 2013.
8. Butler JS, Koutelou E, Schibler AC, Dent SY. Histone-modifying enzymes: regulators of developmental decisions and drivers of human disease. Epigenomics. 2012;4:163-177.
9. Kim HJ, Bae SC. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res. 2011;3:166-179.
10. Pan H, Cao J, Xu W. Selective histone deacetylase inhibitors. Anticancer Agents Med Chem. 2012;12:247-270.